Search

everythinglearnresearchcommunity

for

Search:↓

Male rats have more somatostatin neurons than females due to testosterone converting to estrogen during early development.

Stopping infliximab and using strong topical steroids can regrow hair lost due to psoriasiform alopecia.

Gender affects hair and scalp characteristics, with differences in hormone responses, graying patterns, and trace metals.

Testosterone reduces key molecules needed for early pregnancy in rats.

Alopecia areata treatment should be personalized, using topical or systemic therapies based on severity, with promising options like JAK inhibitors needing more research.

Analog 23 is a promising compound for prostate cancer treatment.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

Androgenetic alopecia involves genetics, hormones, and can be treated with medications or surgery.

Targeting glucocorticoid action might help treat type-2 diabetes, but human trials are needed.

Excessive hair growth in women often has no known cause and is not linked to race or other hormonal symptoms.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

Scientists have developed a new method to detect steroid abuse in athletes using cell-based tests, which could be the future of anti-doping methods.

Sebaceous glands play a key role in skin health, immunity, and various skin diseases.

Some oral medications may help treat central serous chorioretinopathy, especially eplerenone, but more research is needed.

Exposure to certain sex hormones can increase health risks, while some hormone therapies may offer benefits for specific conditions.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

Possible new treatments for common hair loss include drugs, stem cells, and improved transplants.

PFS and PSSD are similar conditions with persistent sexual dysfunction after stopping medication.

A substance called DKK-1 increases in balding areas and causes hair cells to die when exposed to DHT.

Methotrexate treats various disorders by inhibiting DNA synthesis, but careful monitoring is needed to avoid toxicity and manage side effects.

Congenital Adrenal Hyperplasia is a genetic disorder with two forms, causing symptoms like early puberty and severe acne, but can be identified through screening and treated with glucocorticoids.

GABRA2 gene variations impact alcohol response, and hair loss medication finasteride reduces some effects.

Children with atopic dermatitis often have sleep problems, affecting their growth and behavior.

Lowering testosterone speeds up wound healing in male mice.

Anti-TNF therapy can cause a unique type of hair loss that may get better with topical treatments without stopping the therapy.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

The document concludes that early recognition and treatment of primary cicatricial alopecia is crucial to prevent permanent hair loss.

Prolactin affects the production of different keratins in human hair, which could lead to new treatments for skin and hair disorders.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

The skin's ability to produce hormones is linked to various skin conditions, and better understanding this process could lead to new treatments.